Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
64
datasets available to search
ShareScore release 0.9.0
Dataset results
64 results for “central serous chorioretinopathy”
Analysis on Multimodal Imaging of 'stealth' Choroidal Neovascularization in Central Serous Chorioretinopathy
<p><strong>Purpose:</strong> To investigate the prevalence of concurrent choroidal neovascularization (CNV) in patients with clinically diagnosed of central serous chorioretinopathy (CSC) and analyze the multimodal imaging characteristics of CSC with ‘stealth’ CNV (CSC-sCNV). <strong>Design: </strong>Retrospective, observational cross-sectional study. <strong>Methods</strong><strong>:</strong> The current study analyzed the clinical data of 111 clinically diagnosed of CSC patients (134 eyes) who received fluorescein fundus angiography (FFA), indocyanine green angiography (ICGA), and optical coherence tomography angiography (OCTA) at their initial visit. The CSC-CNV that can be detected by FFA+ICG was defined as classic CSC-CNV (CSC-cCNV), and CSC-CNV that cannot be detected by FFA+ICG but can be detected by OCTA was defined as CSC-sCNV. The multimodal imaging characteristics of CSC-sCNV were analyzed.<strong> Results: </strong>The concurrent CNV was found in 29 eyes (21.6%) of 28 patients (25.2%), who were significantly older than those without CNV (P=0.039). Among the 29 eyes, 6 eyes (20.7%) were CSC-cCNV and 23 (79.3%) were CSC-sCNV. All CSC-sCNV eyes were type 1 CNV, of which, 22 had photoreceptor layer defects of varying severities. OCTA showed 4 (17.4%) were active CNV and 19 (82.6%) were inactive CNV based on the morphology features. CSC-sCNV lesions manifested as smoke-stack leakage, diffuse RPE changes with/without ink-blot leakage and normal fluorescence on FFA (1 eye, 7 eyes, 10 eyes and 5 eyes respectively). ICGA showed no typical CNV features in CSC-sCNV but choroidal vasodilation beneath CNV lesions and choroidal hyperpermeability at the posterior pole.<strong> Conclusion:</strong> CSC-sCNV may be the primary phenotype of CSC-CNV and its inactivity might be the reason that it cannot be detected by FFA.</p>
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01325181. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Finasteride for Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01585441. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01982383. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Eplerenone for Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01822561. IPD Sharing: UNDECIDED. Countries: 1. Publications: 13.
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01227993. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01468337. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Eplerenone for the Treatment of Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01990677. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT00837252. IPD Sharing: Not stated. Countries: 1. Publications: 4.
The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01710332. IPD Sharing: NO. Countries: 1. Publications: 2.
Choroidal thickness measurement in central serous chorioretinopathy using swept source optical coherence tomography: an observational study
<p><strong>Choroidal thickness </strong><strong>measurement in central serous chorioretinopathy using swept source optical coherence tomography: an observational study </strong></p>
Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma
ClinicalTrials.gov study NCT04224831. IPD Sharing: NO. Countries: 1. Publications: 7.
Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01327170. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01797861. IPD Sharing: NO. Countries: 4. Publications: 6.
Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT04410861. IPD Sharing: NO. Countries: 1. Publications: 3.
Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT03079141. IPD Sharing: NO. Countries: 1. Publications: 1.
Persona of Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT02819622. IPD Sharing: YES. Countries: 1. Publications: 4.
Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History Study
ClinicalTrials.gov study NCT05278169. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.
The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01630863. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT02153125. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.